TY - JOUR
T1 - Approaches to Understanding COVID-19 and its Neurological Associations
AU - on behalf of the Global COVID-19 Neuro Research Coalition
AU - Beghi, Ettore
AU - Michael, Benedict D.
AU - Solomon, Tom
AU - Westenberg, Erica
AU - Winkler, Andrea S.
AU - Michael, Benedict D.
AU - Westenberg, Erica
AU - Knauss, Samuel
AU - Sejvar, Jim
AU - Siddiqi, Omar
AU - Netravathi, M.
AU - Charway-Felli, Augustina
AU - Abd-Allah, Foad
AU - Bassetti, Claudio
AU - Ferreira, Maria Lúcia Brito
AU - Chou, Sherry Hsiang Yi
AU - Dalmau, Josep
AU - Delgado-García, Guillermo
AU - Easton, Ava
AU - Emmrich, Julius
AU - Endres, Matthias
AU - Fleury, Agnès
AU - Frontera, Jennifer A.
AU - García-Azorín, David
AU - Guekht, Alla
AU - Helbok, Raimund
AU - Hellwig, Kerstin
AU - Höglinger, Günter
AU - Hoo, Fan Kee
AU - Klein, Christine
AU - Lant, Suzannah
AU - McNett, Molly
AU - Moro, Elena
AU - Padovani, Alessandro
AU - Pfausler, Bettina
AU - Prasad, Kameshwar
AU - Roman, Gustavo C.
AU - Sarfo, Fred S.
AU - Satishchandra, Parthasarathy
AU - Saylor, Deanna
AU - Spatola, Marianna
AU - Spencer, Peter
AU - Stark, Richard J.
AU - Synofzik, Matthis
AU - Taba, Pille
AU - Tagliavini, Fabrizio
AU - Thakur, Kiran T.
AU - Umapathi, Thirugnanam
AU - Vijayabala, Jeevagan
AU - Weissenborn, Karin
N1 - Funding Information:
We would like to acknowledge the following organizations for their commitment to monitoring and understanding the neurological manifestations of COVID‐19: the European Academy of Neurology (EAN), the German Society of Neurology (DGN), the Global Consortium Study of Neurological Dysfunction in COVID‐19 (GCS‐NeuroCOVID), the CoroNerve Study Group, the Brain Infections Global COVID‐Neuro Network, the WHO Brain Health Unit with its Neuro‐COVID Global Forum, and the World Federation of Neurology (WFN). We also acknowledge the national registries of Italy, Spain, Germany, USA, and Mexico, with gratitude to their coordinators for providing us with their data collection structures. We also give special thanks to Professor Bernhard Hemmer, Department of Neurology, Technical University of Munich, for his ongoing support of the COVID‐19 Neuro Research Coalition, and to Erica Westenberg and Annette Abraham for coordinating the Coalition. ASW reports funding by the School of Medicine, Technical University of Munich, Grant Number H.40001.1.7‐08 in support of the global COVID‐19 Neuro Research Coalition.
Funding Information:
We would like to acknowledge the following organizations for their commitment to monitoring and understanding the neurological manifestations of COVID-19: the European Academy of Neurology (EAN), the German Society of Neurology (DGN), the Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID), the CoroNerve Study Group, the Brain Infections Global COVID-Neuro Network, the WHO Brain Health Unit with its Neuro-COVID Global Forum, and the World Federation of Neurology (WFN). We also acknowledge the national registries of Italy, Spain, Germany, USA, and Mexico, with gratitude to their coordinators for providing us with their data collection structures. We also give special thanks to Professor Bernhard Hemmer, Department of Neurology, Technical University of Munich, for his ongoing support of the COVID-19 Neuro Research Coalition, and to Erica Westenberg and Annette Abraham for coordinating the Coalition. ASW reports funding by the School of Medicine, Technical University of Munich, Grant Number H.40001.1.7-08 in support of the global COVID-19 Neuro Research Coalition.
Publisher Copyright:
© 2021 American Neurological Association.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
This article is protected by copyright. All rights reserved.
PY - 2021/6
Y1 - 2021/6
N2 - There is an accumulating volume of research into neurological manifestations of coronavirus disease 2019 (COVID-19). However, inconsistent study designs, inadequate controls, poorly validated tests, and differing settings, interventions, and cultural norms weaken study quality and comparability, hence the understanding of the spectrum, burden, and pathophysiology of these complications. Therefore, a global COVID-19 Neuro Research Coalition, together with the World Health Organization, has reviewed reports of COVID-19 neurological complications and harmonized clinical measures for future research. This will facilitate well-designed studies using precise, consistent case definitions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and neurological complications, with standardized forms for pooled data analyses that nonspecialists can use, including those in low-income settings. ANN NEUROL 2021;89:1059–1067.
AB - There is an accumulating volume of research into neurological manifestations of coronavirus disease 2019 (COVID-19). However, inconsistent study designs, inadequate controls, poorly validated tests, and differing settings, interventions, and cultural norms weaken study quality and comparability, hence the understanding of the spectrum, burden, and pathophysiology of these complications. Therefore, a global COVID-19 Neuro Research Coalition, together with the World Health Organization, has reviewed reports of COVID-19 neurological complications and harmonized clinical measures for future research. This will facilitate well-designed studies using precise, consistent case definitions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and neurological complications, with standardized forms for pooled data analyses that nonspecialists can use, including those in low-income settings. ANN NEUROL 2021;89:1059–1067.
UR - http://www.scopus.com/inward/record.url?scp=85105474665&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105474665&partnerID=8YFLogxK
U2 - 10.1002/ana.26076
DO - 10.1002/ana.26076
M3 - Article
C2 - 33836104
AN - SCOPUS:85105474665
SN - 0364-5134
VL - 89
SP - 1059
EP - 1067
JO - Annals of Neurology
JF - Annals of Neurology
IS - 6
ER -